171 related articles for article (PubMed ID: 16370163)
1. Vasculitis and infection: effects of immunosuppressive therapy.
Lode HM; Schmidt-Ioanas M
Clin Nephrol; 2005 Dec; 64(6):475-9. PubMed ID: 16370163
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus pneumonitis complicating immunosuppressive treatment for ANCA-positive vasculitis.
Jones R; Shah S; MacMahon EE; Goldsmith DJ
Nephrol Dial Transplant; 2003 Sep; 18(9):1920-2. PubMed ID: 12937244
[No Abstract] [Full Text] [Related]
3. [Immunology in clinical practice IX. Systemic vasculitis].
Kallenberg CG; Tervaert JW
Ned Tijdschr Geneeskd; 1998 Jan; 142(3):118-23. PubMed ID: 9557008
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody vasculitis associated with mycobacterium avium intracellulare infection.
Chaiamnuay S; Heck LW
J Rheumatol; 2005 Aug; 32(8):1610-2. PubMed ID: 16078343
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis und therapy of ANCA-associated vasculitis].
Aries PM; Hellmich B; Gross WL
Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569
[TBL] [Abstract][Full Text] [Related]
6. Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?
Nachman PH
Nat Rev Nephrol; 2009 May; 5(5):254-6. PubMed ID: 19384325
[TBL] [Abstract][Full Text] [Related]
7. [Vasculitis management: discovery of antineutrophil cytoplasmic antibodies (ANCA)].
Guillevin L
Presse Med; 2007 May; 36(5 Pt 2):843-4. PubMed ID: 17449373
[No Abstract] [Full Text] [Related]
8. Infection-associated vasculitides.
Haq SA; Pagnoux C
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():109-115. PubMed ID: 29624865
[TBL] [Abstract][Full Text] [Related]
9. Update on vasculitis.
Khasnis A; Langford CA
J Allergy Clin Immunol; 2009 Jun; 123(6):1226-36. PubMed ID: 19501230
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based treatment of systemic vasculitis.
Jayne D
Rheumatology (Oxford); 2000 Jun; 39(6):585-95. PubMed ID: 10888702
[No Abstract] [Full Text] [Related]
11. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
Flossmann O; de Groot K
Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
[No Abstract] [Full Text] [Related]
12. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
Levine SM
Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281
[No Abstract] [Full Text] [Related]
13. [Vasculitides: nosological classification and targeted therapies].
Guillevin L
Rev Prat; 2008 Mar; 58(5):479. PubMed ID: 18524102
[No Abstract] [Full Text] [Related]
14. Translational research in autoimmunity: aims of therapy in vasculitis.
Watts R; Harper L; Jayne D; Levy J; Pusey C; Savage C; Scott DG; Williams J
Rheumatology (Oxford); 2005 May; 44(5):573-6. PubMed ID: 15797978
[No Abstract] [Full Text] [Related]
15. Bibliography. Current world literature. Vasculitis syndromes.
Curr Opin Rheumatol; 1999 Jan; 11(1):B1-13. PubMed ID: 9894637
[No Abstract] [Full Text] [Related]
16. Primary systemic vasculitis.
Savage CO; Harper L; Adu D
Lancet; 1997 Feb; 349(9051):553-8. PubMed ID: 9048802
[No Abstract] [Full Text] [Related]
17. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
18. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
Padhan P
Ann Intern Med; 2010 Jan; 152(1):64; author reply 65. PubMed ID: 20048279
[No Abstract] [Full Text] [Related]
19. Pulmonary vasculitis.
Burns A
Br J Hosp Med; 1997 Oct 15-Nov 4; 58(8):389-92. PubMed ID: 9509040
[No Abstract] [Full Text] [Related]
20. [New treatments for systemic diseases].
Bader-Meunier B; Willems M
Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
